The atai stock forecast remains sensitive to catalysts from psychedelic medicine regulatory announcements. A positive ruling could trigger multi-day rallies mirroring 2021 sector surges. atai Life Sciences : This Zacks Rank #2 clinical-stage biopharmaceutical company aims to transform the treatment of mental health disorders. An update from ATAI Life Sciences ( (ATAI) ) is now available. Market correlation analysis in the atai stock forecast shows low beta of 0.68, meaning reduced sensitivity to major index swings — favorable in volatile macro conditions.